LeMaitre Vascular Inc (LMAT) stock
LMATNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 22/3022% below fair value
$75.58−0.52 (-0.68%)
Close on Nov 18, 2026Market cap $1.73BP/E 26.5Yield 1.06%
LeMaitre Vascular operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
LeMaitre Vascular's operating income for the twelve months ending Jun 30, 2026 was $77.32M, up 41.2% year over year. For fiscal 2025 it was $67.91M, up 30.0% from the year before. Over ten years it grew 19.4% a year on average. The highest annual figure on record is $67.91M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $67.91M | +30.0% |
| FY2024 | Dec 31, 2024 | $52.26M | +42.3% |
| FY2023 | Dec 31, 2023 | $36.71M | +36.8% |
| FY2022 | Dec 31, 2022 | $26.83M | -26.3% |
| FY2021 | Dec 31, 2021 | $36.43M | +26.5% |
| FY2020 | Dec 31, 2020 | $28.79M | +35.9% |
| FY2019 | Dec 31, 2019 | $21.18M | -24.9% |
| FY2018 | Dec 31, 2018 | $28.21M | +33.7% |
| FY2017 | Dec 31, 2017 | $21.10M | +29.2% |
| FY2016 | Dec 31, 2016 | $16.34M | +41.9% |
| FY2015 | Dec 31, 2015 | $11.51M | +81.6% |
| FY2014 | Dec 31, 2014 | $6.34M | +40.3% |
| FY2013 | Dec 31, 2013 | $4.52M | +6.6% |
| FY2012 | Dec 31, 2012 | $4.24M | +14.9% |
| FY2011 | Dec 31, 2011 | $3.69M | -8.1% |
| FY2010 | Dec 31, 2010 | $4.02M | +106.0% |
| FY2009 | Dec 31, 2009 | $1.95M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $20.40M | +26.4% |
| Q1 FY2026 | Mar 31, 2026 | $17.78M | +40.8% |
| Q4 FY2025 | Dec 31, 2025 | $18.83M | +46.5% |
| Q3 FY2025 | Sep 30, 2025 | $20.31M | +54.5% |
| Q2 FY2025 | Jun 30, 2025 | $16.14M | +12.3% |
| Q1 FY2025 | Mar 31, 2025 | $12.63M | +6.3% |
| Q4 FY2024 | Dec 31, 2024 | $12.85M | +25.9% |
| Q3 FY2024 | Sep 30, 2024 | $13.15M | +43.2% |
| Q2 FY2024 | Jun 30, 2024 | $14.38M | +52.1% |
| Q1 FY2024 | Mar 31, 2024 | $11.87M | +50.8% |
| Q4 FY2023 | Dec 31, 2023 | $10.21M | +46.5% |
| Q3 FY2023 | Sep 30, 2023 | $9.18M | +49.3% |
| Q2 FY2023 | Jun 30, 2023 | $9.45M | +63.4% |
| Q1 FY2023 | Mar 31, 2023 | $7.87M | -0.7% |
| Q4 FY2022 | Dec 31, 2022 | $6.97M | -16.1% |
| Q3 FY2022 | Sep 30, 2022 | $6.15M | -32.2% |
| Q2 FY2022 | Jun 30, 2022 | $5.78M | -47.9% |
| Q1 FY2022 | Mar 31, 2022 | $7.93M | -0.2% |
| Q4 FY2021 | Dec 31, 2021 | $8.30M | -13.0% |
| Q3 FY2021 | Sep 30, 2021 | $9.07M | -9.4% |
| Q2 FY2021 | Jun 30, 2021 | $11.11M | +128.0% |
| Q1 FY2021 | Mar 31, 2021 | $7.95M | +82.5% |
| Q4 FY2020 | Dec 31, 2020 | $9.55M | +93.7% |
| Q3 FY2020 | Sep 30, 2020 | $10.02M | +69.7% |
| Q2 FY2020 | Jun 30, 2020 | $4.87M | -17.6% |
| Q1 FY2020 | Mar 31, 2020 | $4.35M | -1.8% |
| Q4 FY2019 | Dec 31, 2019 | $4.93M | -31.5% |
| Q3 FY2019 | Sep 30, 2019 | $5.91M | +28.0% |
| Q2 FY2019 | Jun 30, 2019 | $5.92M | -48.7% |
| Q1 FY2019 | Mar 31, 2019 | $4.44M | -8.8% |
| Q4 FY2018 | Dec 31, 2018 | $7.19M | +13.8% |
| Q3 FY2018 | Sep 30, 2018 | $4.61M | -8.7% |
| Q2 FY2018 | Jun 30, 2018 | $11.54M | +108.5% |
| Q1 FY2018 | Mar 31, 2018 | $4.86M | +16.0% |
| Q4 FY2017 | Dec 31, 2017 | $6.32M | +61.7% |
| Q3 FY2017 | Sep 30, 2017 | $5.05M | -5.4% |
| Q2 FY2017 | Jun 30, 2017 | $5.54M | – |
| Q1 FY2017 | Mar 31, 2017 | $4.19M | – |
| Q4 FY2016 | Dec 31, 2016 | $3.91M | – |
| Q3 FY2016 | Sep 30, 2016 | $5.34M | – |
See a number that looks wrong?